SIX2 and CITED1, markers of nephronic progenitor self-renewal, remain active in primitive elements of Wilms' tumor

Journal of Pediatric Surgery

Volumn 47, Issue 6, 2012, Pages 1239-1249

  Murphy, Andrew J ^a   Pierce, Janene ^a   De Caestecker, Christian ^a   Taylor, Chase ^a   Anderson, James R ^b   Perantoni, Alan O ^c   De Caestecker, Mark P ^d   Lovvorn III, Harold N ^a  

^a MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CITED1; Embryonic kidney; SIX2; Wilms' tumor

Indexed keywords

CELL PROTEIN; MESSENGER RNA; PROTEIN CITED1; PROTEIN SIX2; UNCLASSIFIED DRUG;

CANCER STAGING; CELL POPULATION; CELL RENEWAL; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INFANT; MAJOR CLINICAL STUDY; MALE; NEPHROBLASTOMA; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL; TREATMENT FAILURE; TREATMENT OUTCOME; WESTERN BLOTTING;

EID: 84862503966     PISSN: 00223468     EISSN: 15315037     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2012.03.034     Document Type: Conference Paper

References (25)

1. Li CM, Guo M, Borczuk A, et al. Gene expression in Wilms tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition. Am J Pathol 2002;160:2181-90. (Pubitemid 34663409)
2. Davidoff AM. Wilms' tumor. Curr Opin Pediatr 2009;21:357-64.
3. Saxen L, Sariola H. Early organogenesis of the kidney. Pediatr Nephrol 1987;1:385-92. (Pubitemid 18016633)
4. Hendry C, Rumballe B, Moritz K, et al. Defining and redefining the nephron progenitor population. Pediatr Nephrol 2011.
5. Kobayashi A, Valerius MT, Mugford JW, et al. Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development. Cell Stem Cell 2008;3:169-81.
6. Boyle S, Misfeldt A, Chandler KJ, et al. Fate mapping using Cited1-CreERT2 mice demonstrates that the cap mesenchyme contains selfrenewing progenitor cells and gives rise exclusively to nephronic epithelia. Dev Biol 2008;313:234-45. (Pubitemid 350298313)
7. Boyle S, Shioda T, Perantoni AO, et al. Cited1 and Cited2 are differentially expressed in the developing kidney but are not required for nephrogenesis. Dev Dyn 2007;236:2321-30. (Pubitemid 47293774)
8. Self M, Lagutin OV, Bowling B, et al. Six2 is required for suppression of nephrogenesis and progenitor renewal in the developing kidney. EMBO J 2006;25:5214-28. (Pubitemid 44658538)
9. Rivera MN, Haber DA. Wilms' tumour: connecting tumorigenesis and organ development in the kidney. Nat Rev Cancer 2005;5:699-712. (Pubitemid 41486363)
10. Lovvorn HN, Westrup J, Opperman S, et al. CITED1 expression in Wilms' tumor and embryonic kidney. Neoplasia 2007;9:589-600. (Pubitemid 47121833)
11. Lovvorn III HN, Boyle S, Shi G, et al. Wilms' tumorigenesis is altered by misexpression of the transcriptional co-activator, CITED1. J Pediatr Surg 2007;42:474-81.
12. Shi G, Boyle SC, Sparrow DB, et al. The transcriptional activity of CITED1 is regulated by phosphorylation in a cell cycle-dependent manner. J Biol Chem 2006;281:27426-35. (Pubitemid 44403814)
13. Mugford JW, Yu J, Kobayashi A, et al. High-resolution gene expression analysis of the developing mouse kidney defines novel cellular compartments within the nephron progenitor population. Dev Biol 2009;333:312-23.
14. Huff V. Wilms' tumours: about tumour suppressor genes, an oncogene and a chameleon gene. Nat Rev Cancer 2011;11:111-21.
15. Dressler GR, Douglass EC. Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor. Proc Natl Acad Sci USA 1992;89:1179-83.
16. Paik S, Rosen N, Jung W, et al. Expression of insulin-like growth factor-II mRNA in fetal kidney and Wilms' tumor. An in situ hybridization study. Lab Invest 1989;61:522-6. (Pubitemid 20007115)
17. Hu Q, Gao F, Tian W, et al. Wt1 ablation and Igf2 upregulation in mice result in Wilms tumors with elevated ERK1/2 phosphorylation. J Clin Invest 2011;121:174-83.
18. Timofeeva OA, Plisov S, Evseev AA, et al. Serine-phosphorylated STAT1 is a prosurvival factor in Wilms' tumor pathogenesis. Oncogene 2006;25:7555-64. (Pubitemid 44924469)
19. Wang H, Yang Y, Sharma N, et al. STAT1 activation regulates proliferation and differentiation of renal progenitors. Cell Signal 2010;22:1717-26.
20. Levashova ZB, Sharma N, Timofeeva OA, et al. ELR+-CXC chemokines and their receptors in early metanephric development. J Am Soc Nephrol 2007;18:2359-70. (Pubitemid 47208110)
21. Aiden AP, Rivera MN, Rheinbay E, et al. Wilms tumor chromatin profiles highlight stem cell properties and a renal developmental network. Cell Stem Cell 2010;6:591-602.
22. Metsuyanim S, Pode-Shakked N, Schmidt-Ott KM, et al. Accumulation of malignant renal stem cells is associated with epigenetic changes in normal renal progenitor genes. Stem Cells 2008;26:1808-17.
23. Koesters R, Niggli F, von Knebel Doeberitz M, et al. Nuclear accumulation of beta-catenin protein in Wilms' tumours. J Pathol 2003;199:68-76.
24. Ehrlich D, Bruder E, Thome MA, et al. Nuclear accumulation of beta-catenin protein indicates activation of wnt signaling in chemically induced rat nephroblastomas. Pediatr Dev Pathol 2010;13:1-8.
25. Ruteshouser EC, Robinson SM, Huff V. Wilms tumor genetics: mutations in WT1, WTX, and CTNNB1 account for only about one-third of tumors. Genes Chromosomes Cancer 2008;47:461-70. (Pubitemid 351657181)